Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting immunostaining in relation to complex human pathologies.TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding. Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
BRS3 is classified as an Orphan-A Receptor and is highly similar to the bombesin receptors but has a very low affinity for bombesin itself. Mice lacking BRS3 develop metabolic defects and obesity, suggesting that BRS3 may be an important target for obesity research. In addition, BRS3 may be involved in diabetes and hypertension.
|Gene Name:||bombesin-like receptor 3|
|Family/Subfamily:||GPCR , Orphan-A|
|Synonyms:||BRS3, BB3 receptor, Bombesin-like receptor 3, Bombesin receptor subtype 3, Bombesin receptor subtype-3, BRS-3, BLP receptor subtype 3, Bombesin receptor 3|
|Target Sequences:||NM_001727 NP_001718.1 P32247|
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.